A Pilot Testing of the Effect of Guided Meditation on Anxiety, Depression and Sleep Quality among COVID-19 Patients Admitted in a Tertiary Care Facility
Devanshi Chowdhary, Suman Dabas, P. Joshi, A. Trikha
Journal of Complementary and Alternative Medical Research 2021 DOI: 10.9734/jocamr/2021/v15i430272 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Sample size | 60 |
| Population | Hospitalized COVID-19 patients in a tertiary care facility |
| Intervention | Guided meditation |
| Duration | 20 minutes twice a day for 5 consecutive days |
| Topics | Anxiety Depression Meditation |
| Key findings | Guided meditation, delivered twice daily for five days, was associated with lower post-test anxiety and depression scores and better global sleep quality compared with standard routine care in hospitalized COVID-19 patients. |
Abstract
Hospitalization of COVID- 19 patients may lead to the development of varied levels of anxiety, depression, and sleep disturbances. The present study was conceptualized to investigate the effect of guided meditation on anxiety, depression, and sleep quality among the hospitalized Covid-19 patients in a tertiary care facility.
Materials and Methods: A total of 60 COVID-19 patients were conveniently enrolled and randomized to experimental (30) and control arms (30) using a computer-generated random table and opaque sealed envelope technique in a selected COVID unit of a tertiary care facility. The subjects were enrolled in accordance to the inclusion criteria. Intervention: The guided meditation was an audio recording of Sri Sri Ravi Shankar of 20 minutes duration. The intervention was provided twice a day to the experimental group for consecutive 5 days. A close watch was kept on the vital signs of the subjects during the intervention using a pulse oximeter. At the same time, the control group continued to receive the standard routine care.
Results: There was a significant difference observed in the post-test anxiety and depression scores in the experiment and control groups (4.83±3.68 vs. 12.37±3.9 p=0.001 and 7.90±2.41 vs.12.67±2.65 p=0.001). A significant difference was also observed in the global sleep quality index (median (IQR)) in the experimental and control groups (11(9-14) vs. 15(10.75-17) p= 0.01).
Conclusion: The guided meditation was effective in improving the global sleep quality index and alleviating the anxiety and depression to great extent as compared to the standard routine care provided to COVID-19 patients admitted in a tertiary care facility.
Comparable studies
Other randomized controlled trials on anxiety, most cited first.
Citations in the library
Cites 5
- The effect of mindfulness meditation on sleep quality: a systematic review and meta‐analysis of randomized controlled trials Annals of the New York Academy of Sciences December 21, 2018
- Mindfulness Meditation and Improvement in Sleep Quality and Daytime Impairment Among Older Adults With Sleep Disturbances JAMA Internal Medicine February 16, 2015
- The benefits of meditation and mindfulness practices during times of crisis such as COVID-19 Irish Journal of Psychological Medicine May 14, 2020
- Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature. Drug and Alcohol Dependence May 8, 2013
- Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. International Journal of Behavioral Medicine 2005